1. Home
  2. FULC vs TG Comparison

FULC vs TG Comparison

Compare FULC & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

N/A

Current Price

$3.69

Market Cap

281.1M

Sector

Health Care

ML Signal

N/A

Logo Tredegar Corporation

TG

Tredegar Corporation

SELL

Current Price

$5.46

Market Cap

239.6M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
FULC
TG
Founded
2015
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
281.1M
239.6M
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
FULC
TG
Price
$3.69
$5.46
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $3.67
N/A
AVG Volume (30 Days)
★ 1.2M
263.5K
Earning Date
11-12-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 151.06
EPS
N/A
★ 0.26
Revenue
N/A
★ $800,821,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$21.73
Revenue Growth
N/A
★ 8.29
52 Week Low
$2.83
$5.26
52 Week High
$15.74
$10.53

Technical Indicators

Market Signals
Indicator
FULC
TG
Relative Strength Index (RSI) 45.53 30.65
Support Level $3.62 $5.26
Resistance Level $3.81 $8.15
Average True Range (ATR) 0.06 0.41
MACD -0.00 -0.08
Stochastic Oscillator 7.69 8.97

Price Performance

Historical Comparison
FULC
TG

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

Share on Social Networks: